Lilly(Eli) (LLY) Income Statement
Is this a real, growing, cash-generative business, or a story propped up by accounting?
911.7mn → 899.3mn diluted shares since FY21. Broadly flat, so EPS moves with net income rather than with the share count.
▲55% YoY in FY25, largest jump in this window; watch free-cash-flow conversion.
$9.5B returned vs $9.0B of FCF in FY25. The gap comes off the balance sheet (see net cash).
32¢ of every revenue dollar becomes profit. The biggest cost lever is operating expenses.
Over this window: gross 74.2% → 83.0%. Net margin 31.7% is more than double the sector median.
| Line item | TTM † | FY25 | FY24 | FY23 | FY22 | FY21 | YoY | CAGR 21→25 |
|---|---|---|---|---|---|---|---|---|
| Revenue & profitability | ||||||||
Revenue | 86,461.0 | 65,179.0 | 45,043.0 | 34,124.0 | 28,541.4 | 28,318.4 | ▲44.7% | +23.2% |
Cost of revenue | 14,149.0 | 11,052.0 | 8,418.0 | 7,082.0 | 6,629.8 | 7,312.8 | ▲31.3% | +10.9% |
Gross profit | 72,312.0 | 54,127.0 | 36,625.0 | 27,042.0 | 21,911.6 | 21,005.6 | ▲47.8% | +26.7% |
Research & development | 23,446.0 | 16,247.0 | 14,271.0 | 13,113.0 | 8,099.3 | 7,900.8 | ▲13.8% | +19.8% |
Selling, general & admin | 12,621.0 | 11,094.0 | 8,594.0 | 7,404.0 | 6,440.4 | 6,431.6 | ▲29.1% | +14.6% |
Total operating expenses | 37,436.0 | 27,825.0 | 23,726.0 | 20,585.0 | 14,784.3 | 14,648.5 | ▲17.3% | +17.4% |
Operating incomefeeds ROC rank | 34,876.0 | 26,302.0 | 12,899.0 | 6,457.0 | 7,127.3 | 6,357.1 | ▲103.9% | +42.6% |
Other income, net | −108.0 | −571.0 | −219.0 | 97.0 | −320.9 | −201.6 | — | — |
Pretax income | 34,768.0 | 25,731.0 | 12,680.0 | 6,554.0 | 6,806.4 | 6,155.5 | ▲102.9% | +43.0% |
Income tax | 7,189.0 | 5,091.0 | 2,090.0 | 1,314.0 | 561.6 | 573.8 | ▲143.6% | +72.6% |
Net incomePiotroski ROA ✓feeds Buffett Quality owner earnings | 27,579.0 | 20,640.0 | 10,590.0 | 5,240.0 | 6,244.8 | 5,581.7 | ▲94.9% | +38.7% |
| Per share | ||||||||
Diluted EPSbuyback-sensitive | 30.81 | 22.95 | 11.71 | 5.80 | 6.90 | 6.12 | ▲96.0% | +39.2% |
Diluted shares (mn) | 893.40 | 899.30 | 904.10 | 903.30 | 904.62 | 911.68 | ▼0.5% | −0.3% |
| Margins | ||||||||
Gross margin78th pct in Healthcare | 83.6% | 83.0% | 81.3% | 79.2% | 76.8% | 74.2% | ▲1.7pp | +8.9pp |
Operating margin | 40.3% | 40.4% | 28.6% | 18.9% | 25.0% | 22.4% | ▲11.7pp | +17.9pp |
Net margin95th pct in Healthcare | 31.9% | 31.7% | 23.5% | 15.4% | 21.9% | 19.7% | ▲8.2pp | +12.0pp |
Statements normalized in our fundamentals DB · Not investment advice.
Common questions
What was Lilly(Eli)'s revenue last fiscal year?
Lilly(Eli) reported revenue of $65.2B in fiscal 2025, up 44.7% from fiscal 2024.
What was Lilly(Eli)'s net income?
Lilly(Eli) reported net income of $20.6B in fiscal 2025, a net margin of 31.7%.

